Name: IBRX Balance Sheet - Immunitybio Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

IBRX - Immunitybio, Inc.

USD | NASDAQ | Healthcare

IBRX Balance Sheet - Immunitybio Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012
Cash And Short Term Investments
Cash And Equivalents	88.3	143.4	265.5	104.6	181.1	34.9	75.8	16.8	23.9	8.1	175.9	59.1	0.4	0.1
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	154.5	6.4	1.0	2.5	136.0	61.1	-	-	104.3	190.8	118.3	-	-	-
Cash And Short Term Investments	242.8	149.8	266.5	107.2	317.1	96.1	75.8	16.8	128.2	198.9	294.2	59.1	0.4	0.1
Receivables
Accounts Receivable	42.6	2.4	0.0	-	-	-	-	-	-	-	-	0.1	-	-
Current Assets
Inventory	0.9	8.3	0.0	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses
Non-Current Assets
Property, Plant & Equipment Gross	226.7	236.7	230.5	212.9	135.9	114.4	79.1	88.4	81.0	20.1	5.7	0.3	-	-
Current Liabilities
Accounts Payable	-	-	-	21.0	11.4	11.5	1.7	2.8	5.9	4.0	2.1	1.1	-	-
Short Term Debt
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current
Common Equity
Common Stock	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-
Additional Paid In Capital
Supplementary Data
Total Debt	1.8	1.2	-	-	-	-	-	-	-	-	-	-	-	-
Net debt

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Cash And Short Term Investments
Cash And Equivalents	205.2	88.3	60.2	137.7	60.7	143.4	112.0	130.1	133.0	265.5	178.0	43.5	88.5	104.6	104.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	0.5	0.9	6.7	6.6	8.4	8.3	2.0	1.8	-	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	28.3	28.5	32.9	25.5	21.7	23.9	25.9	21.0	23.1	25.6	23.0	18.8	20.8	31.5	30.5	30.6	16.1	15.9
Other Current Assets	3.0	2.1	2.5	1.6	2.4	1.3	1.4	0.5	2.6	1.5	4.4	4.6	4.4	3.7	3.2	3.0	4.0
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	453.0	314.9	329.5	208.1	109.2	184.6	163.2	242.8	195.7	294.1	215.1	66.8	113.5	140.6	143.1	115.0

Non-Current Assets
Property, Plant & Equipment Gross	228.5	226.7	238.8	238.9	238.2	236.7	235.4	234.2	231.9	230.5	233.1	229.1	227.6	212.9	195.0	180.1	162.1	135.9	119.4	137.1	125.4	114.4	80.7	81.7	79.4	79.1	78.5	79.3	79.9	88.4	86.6	85.4	82.2	81.0	77.7	62.8	24.4	20.1	17.1	9.8
Accumulated Depreciation	115.7	112.5	109.3	105.9	102.9	99.6	96.1	92.3	88.4	84.4	81.1	77.6	73.4	69.3	64.6	60.7	56.8
Property,Plant & Equipment Net	112.8	114.3	129.6	133.0	135.3	137.1	139.3	142.0	143.5	146.1	152.0	151.5	154.2	143.7	130.4	119.4
Long Term Investments	-	-	-	-	-	-	0.0	0.0	0.0	0.9	0.8	0.8	0.8	0.8	0.8	0.9	0.9
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	0.9	0.9	0.9	0.9	0.9	0.9	0.9	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	11.9	13.0	13.5	13.5	14.0	0.5	15.0	16.1	16.6	17.1	18.5	19.0	19.5	20.0	20.5	21.7	22.3
Operating Lease Right Of Use Assets	33.0	33.0	33.2	34.7	31.8	33.4	34.9	33.8	35.2	36.5	35.8	42.6	44.2	45.8	46.4	48.1
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	-	-	-	-	-	-	3.6	2.7	2.7	2.9	3.4	3.8	4.5	4.9	5.1	6.0	6.5
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	646.6	501.9	519.0	402.1	303.8	382.9	364.6	444.3	400.7	504.5	432.4	291.2	343.4	362.4	352.9	317.7	389.6

Current Liabilities
Accounts Payable	-	-	-	-	-	-	-	-	-	-	-	-	33.6	21.0	20.2	18.1	9.8	11.4	15.1	19.2	20.1	11.5	6.2	4.0	3.1	1.7	2.1	1.9	2.8	2.8	3.5	5.5	3.6	5.9	9.5	4.3	4.3	4.0	2.2	3.3
Short Term Debt	0.9	1.8	2.6	-	-	1.2	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	7.6	7.5	7.3	7.4	7.5	7.5	7.0	6.2	6.1	5.2	4.4	6.0	2.8	2.7	1.4	1.4
Accrued Expenses	48.2	46.8	43.6	35.7	27.9	40.6	43.6	35.3	32.7	42.7	64.9	62.3	54.1	41.8	46.2	52.4	62.5	51.4
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	68.0	61.8	57.1	50.6	49.2	54.9	61.0	62.1	53.8	58.3	90.3	613.5	564.9	500.9	70.8

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	33.1	33.4	34.1	35.8	33.1	34.8	36.8	36.4	38.2	39.9	39.3	44.6	46.3	48.0	49.6	50.6
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.2	0.2
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	0.5	0.4	0.7	0.7	0.4	0.3	0.7	0.7	1.3	1.1	0.5	0.5	0.5	0.5	0.6	0.3
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	1,515.8	1,001.5	1,042.4	971.9	894.2	871.1	1,108.7	1,141.7	1,091.7	1,090.4	843.1	936.4	875.1	812.2	782.0	739.7

Common Equity
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(4,359.4)	(3,726.6)	(3,664.7)	(3,597.4)	(3,504.9)	(3,375.2)	(3,316.1)	(3,230.4)	(3,095.8)	(2,961.7)	(2,728.3)	(2,632.7)	(2,494.8)	(2,378.5)	(2,270.3)	(2,159.3)	(2,064.7)
Accumulated Other Comprehensive Income	27.5	29.0	5.0	12.6	20.0	1.2	0.1	(0.0)	(0.0)	0.0	0.8	(0.0)	(0.0)	0.2	(0.2)	(0.1)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	0.9	0.9	0.9	0.9	0.9	1.0	1.0	1.0	1.0	1.1	1.1	(3.1)	(2.7)	(2.5)	(2.4)	(2.2)	(1.9)
Total Stockholders Equity	(870.0)	(500.5)	(524.3)	(570.7)	(591.4)	(489.1)	(745.1)	(698.4)	(692.0)	(587.0)	(411.7)	(642.1)	(529.0)	(447.3)	(426.7)	(419.8)
Total Equity	(869.1)	(499.6)	(523.4)	(569.8)	(590.5)	(488.1)	(744.2)	(697.4)	(691.0)	(585.9)	(410.6)	(645.2)	(531.7)	(449.8)	(429.1)	(422.0)	(337.6)	(243.9)

Receivables
Accounts Receivable	43.3	42.6	32.0	22.1	17.0	2.4	4.2	1.0	-	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-